Bleeding events in Chinese children with severe hemophilia A receiving standard prophylaxis vs on-demand treatment with Bayer's sucrose-formulated recombinant factor VIII
机构：[1]Beijing Union Med Coll Hosp, Beijing, Peoples R China;[2]Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China;[3]Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China;[4]Peking Union Med Coll, Tianjin, Peoples R China;[5]Beijing Childrens Hosp, Beijing, Peoples R China;首都医科大学附属北京儿童医院[6]Capital Med Univ, Beijing, Peoples R China;[7]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China;[8]Bayer Pharma AG, Wuppertal, Germany;[9]Bayer HealthCare Co Ltd, Beijing, Peoples R China;[10]Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
第一作者机构：[1]Beijing Union Med Coll Hosp, Beijing, Peoples R China;
推荐引用方式(GB/T 7714)：
Zhao Y.,Xiao J.,Yang R.,et al.Bleeding events in Chinese children with severe hemophilia A receiving standard prophylaxis vs on-demand treatment with Bayer's sucrose-formulated recombinant factor VIII[J].JOURNAL OF THROMBOSIS AND HAEMOSTASIS.2015,13:858-858.
APA：
Zhao, Y.,Xiao, J.,Yang, R.,Wu, R.,Hu, Y....&Sun, J..(2015).Bleeding events in Chinese children with severe hemophilia A receiving standard prophylaxis vs on-demand treatment with Bayer's sucrose-formulated recombinant factor VIII.JOURNAL OF THROMBOSIS AND HAEMOSTASIS,13,
MLA：
Zhao, Y.,et al."Bleeding events in Chinese children with severe hemophilia A receiving standard prophylaxis vs on-demand treatment with Bayer's sucrose-formulated recombinant factor VIII".JOURNAL OF THROMBOSIS AND HAEMOSTASIS 13.(2015):858-858
医学